"I must consider the best interests of Bristol-Myers Squibb Company and its shareholders, " Dolan wrote.

FORBES: Magazine Article

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has determined that additional time is required to complete the review of the biologics license application (BLA) for ipilimumab in pre-treated advanced melanoma, and has moved its decision date from December 25, 2010 to March 26, 2011.

FORBES: Immune-Boosting Cancer Drug Hits FDA Delay

Bristol-Myers Squibb, a big pharmaceuticals company, also certified its results with caveats.

ECONOMIST: Swearing by the numbers

Soon after Qwest Communications, the biggest local-telephone company in 14 states, joined the list of firms under investigation, it was revealed that the Securities and Exchange Commission (SEC) is looking into the sales practices of Bristol-Myers Squibb, a big drug company.

ECONOMIST: Congress gets tough | The

Vasella has been playing the waiting game quite a bit--analysts love to speculate that Novartis will buy another drug company, like Roche or maybe Bristol-Myers Squibb (nyse: BMY - news - people ).

FORBES: Novartis CEO Plays Waiting Game

The last drug company to try and buy a potential blockbuster from a biotechnology company was Bristol-Myers Squibb (nyse: BMY - news - people ).

FORBES: How Will Pharmacia Spend Its New Money?

But the best fit may be with a U.S. company, such as Bristol-Myers Squibb, Abbot Labs or even Baxter International.

FORBES: Beyond the bad at Bayer

But because Novartis' field force is still smaller than Pfizer's or GlaxoSmithKline's, the company has signed on Bristol-Myers Squibb to comarket Zelmac.

FORBES: Reviving Novartis

It helps Bristol-Myers Squibb play in the emerging hepatitis C market by giving the company full control of the drug the two firms were developing together.

FORBES: Bristol's Smart Buy

Among the chemotherapy medicines that bind to tubulin are Taxol, the drug that built Bristol-Myers Squibb (nyse: BMY - news - people ) as an oncology company, and Taxotere, the current lynchpin in Aventis ' (nyse: AVE - news - people ) anti-cancer stable.

FORBES: Investors Applaud Tularik's Baby Step

Bristol-Myers Squibb ( BMY - news - people ) moved slightly higher after a federal panel said the company's diabetes drug appears free from the kinds of heart problems seen with similar drugs.

FORBES: This is a transcript of the After Hours video report.